Similar to the agomelatine case study, both ASKCOS and IBM RXN predictors were evaluated to see if the main impurity is predicted, as shown in Figure . ASKCOS was unable to suggest the main products, and the impurity prediction module could not process the inputs. IBM RXN was able to suggest the main product, but its alternative suggestions did not align with the expected impurities.